JLF Collaborators
JLF collaborators are at the forefront of medicine and science. Each is an industry leader providing cutting-edge expertise and technology at every step. JLF consults with the patient and helps them navigate the entire process
CSBio is a leading peptide and instrumentation manufacturing company located on the edge of Silicon Valley in Menlo Park, California. Since 1993, CSBio has been providing high quality custom peptides, cGMP peptides and automated peptide synthesizers to the global pharmaceutical community. CSBio peptide products and instrumentation can be found in production laboratories and pharmaceutical companies worldwide, and it is the vaccine manufacturer for the Jaime Leandro Foundation (JLF).
ennov1 empowers cancer patients to identify personalized treatment options created from their genomic data. Its cloud-based platform provides a clear way to manage your entire cancer journey from diagnosis and disease progression through treatment response and regression. As a JLF partner, ennov1 uses sequencing bioinformatics to predict neoantigens and designs vaccine peptide components.
xCures Inc. operates an AI-assisted platform that connects cancer patients and physicians with optimal investigational or approved therapies. The platform prospectively generates real-world evidence for clinical studies and decentralized trials. As a JLF partner, xCures manages the patient protocol startup and consent with the treating physician, and through the XCELSIOR outcomes registry, centrally collects medical records and safety data.